Cargando…

Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study

To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Machida, Masaki, Kikuchi, Hiroyuki, Kojima, Takako, Nakamura, Itaru, Saito, Reiko, Nakaya, Tomoki, Hanibuchi, Tomoya, Takamiya, Tomoko, Odagiri, Yuko, Fukushima, Noritoshi, Amagasa, Shiho, Watanabe, Hidehiro, Inoue, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621029/
https://www.ncbi.nlm.nih.gov/pubmed/35708308
http://dx.doi.org/10.1080/21645515.2022.2086773
_version_ 1784821448604385280
author Machida, Masaki
Kikuchi, Hiroyuki
Kojima, Takako
Nakamura, Itaru
Saito, Reiko
Nakaya, Tomoki
Hanibuchi, Tomoya
Takamiya, Tomoko
Odagiri, Yuko
Fukushima, Noritoshi
Amagasa, Shiho
Watanabe, Hidehiro
Inoue, Shigeru
author_facet Machida, Masaki
Kikuchi, Hiroyuki
Kojima, Takako
Nakamura, Itaru
Saito, Reiko
Nakaya, Tomoki
Hanibuchi, Tomoya
Takamiya, Tomoko
Odagiri, Yuko
Fukushima, Noritoshi
Amagasa, Shiho
Watanabe, Hidehiro
Inoue, Shigeru
author_sort Machida, Masaki
collection PubMed
description To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR: 1.73, 95%CI: 1.18–2.54; OR: 1.58, 95%CI: 1.22–2.05; OR: 3.05, 95%CI: 2.15–4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic.
format Online
Article
Text
id pubmed-9621029
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-96210292022-11-01 Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study Machida, Masaki Kikuchi, Hiroyuki Kojima, Takako Nakamura, Itaru Saito, Reiko Nakaya, Tomoki Hanibuchi, Tomoya Takamiya, Tomoko Odagiri, Yuko Fukushima, Noritoshi Amagasa, Shiho Watanabe, Hidehiro Inoue, Shigeru Hum Vaccin Immunother Coronavirus – Research Paper To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR: 1.73, 95%CI: 1.18–2.54; OR: 1.58, 95%CI: 1.22–2.05; OR: 3.05, 95%CI: 2.15–4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic. Taylor & Francis 2022-06-16 /pmc/articles/PMC9621029/ /pubmed/35708308 http://dx.doi.org/10.1080/21645515.2022.2086773 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Coronavirus – Research Paper
Machida, Masaki
Kikuchi, Hiroyuki
Kojima, Takako
Nakamura, Itaru
Saito, Reiko
Nakaya, Tomoki
Hanibuchi, Tomoya
Takamiya, Tomoko
Odagiri, Yuko
Fukushima, Noritoshi
Amagasa, Shiho
Watanabe, Hidehiro
Inoue, Shigeru
Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
title Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
title_full Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
title_fullStr Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
title_full_unstemmed Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
title_short Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
title_sort individual-level social capital and covid-19 vaccine hesitancy in japan: a cross-sectional study
topic Coronavirus – Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621029/
https://www.ncbi.nlm.nih.gov/pubmed/35708308
http://dx.doi.org/10.1080/21645515.2022.2086773
work_keys_str_mv AT machidamasaki individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT kikuchihiroyuki individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT kojimatakako individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT nakamuraitaru individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT saitoreiko individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT nakayatomoki individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT hanibuchitomoya individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT takamiyatomoko individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT odagiriyuko individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT fukushimanoritoshi individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT amagasashiho individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT watanabehidehiro individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy
AT inoueshigeru individuallevelsocialcapitalandcovid19vaccinehesitancyinjapanacrosssectionalstudy